Otolemur garnettii (small-eared galago): 100957343
Help
Entry
100957343 CDS
T07855
Symbol
MAPK3
Name
(RefSeq) mitogen-activated protein kinase 3
KO
K04371
mitogen-activated protein kinase 1/3 [EC:
2.7.11.24
]
Organism
oga
Otolemur garnettii (small-eared galago)
Pathway
oga01521
EGFR tyrosine kinase inhibitor resistance
oga01522
Endocrine resistance
oga01524
Platinum drug resistance
oga04010
MAPK signaling pathway
oga04012
ErbB signaling pathway
oga04014
Ras signaling pathway
oga04015
Rap1 signaling pathway
oga04022
cGMP-PKG signaling pathway
oga04024
cAMP signaling pathway
oga04062
Chemokine signaling pathway
oga04066
HIF-1 signaling pathway
oga04068
FoxO signaling pathway
oga04071
Sphingolipid signaling pathway
oga04072
Phospholipase D signaling pathway
oga04114
Oocyte meiosis
oga04140
Autophagy - animal
oga04148
Efferocytosis
oga04150
mTOR signaling pathway
oga04151
PI3K-Akt signaling pathway
oga04210
Apoptosis
oga04218
Cellular senescence
oga04261
Adrenergic signaling in cardiomyocytes
oga04270
Vascular smooth muscle contraction
oga04350
TGF-beta signaling pathway
oga04360
Axon guidance
oga04370
VEGF signaling pathway
oga04371
Apelin signaling pathway
oga04380
Osteoclast differentiation
oga04510
Focal adhesion
oga04520
Adherens junction
oga04540
Gap junction
oga04550
Signaling pathways regulating pluripotency of stem cells
oga04611
Platelet activation
oga04613
Neutrophil extracellular trap formation
oga04620
Toll-like receptor signaling pathway
oga04621
NOD-like receptor signaling pathway
oga04625
C-type lectin receptor signaling pathway
oga04650
Natural killer cell mediated cytotoxicity
oga04657
IL-17 signaling pathway
oga04658
Th1 and Th2 cell differentiation
oga04659
Th17 cell differentiation
oga04660
T cell receptor signaling pathway
oga04662
B cell receptor signaling pathway
oga04664
Fc epsilon RI signaling pathway
oga04666
Fc gamma R-mediated phagocytosis
oga04668
TNF signaling pathway
oga04713
Circadian entrainment
oga04720
Long-term potentiation
oga04722
Neurotrophin signaling pathway
oga04723
Retrograde endocannabinoid signaling
oga04724
Glutamatergic synapse
oga04725
Cholinergic synapse
oga04726
Serotonergic synapse
oga04730
Long-term depression
oga04810
Regulation of actin cytoskeleton
oga04910
Insulin signaling pathway
oga04912
GnRH signaling pathway
oga04914
Progesterone-mediated oocyte maturation
oga04915
Estrogen signaling pathway
oga04916
Melanogenesis
oga04917
Prolactin signaling pathway
oga04919
Thyroid hormone signaling pathway
oga04921
Oxytocin signaling pathway
oga04926
Relaxin signaling pathway
oga04928
Parathyroid hormone synthesis, secretion and action
oga04929
GnRH secretion
oga04930
Type II diabetes mellitus
oga04933
AGE-RAGE signaling pathway in diabetic complications
oga04934
Cushing syndrome
oga04935
Growth hormone synthesis, secretion and action
oga04960
Aldosterone-regulated sodium reabsorption
oga05010
Alzheimer disease
oga05020
Prion disease
oga05022
Pathways of neurodegeneration - multiple diseases
oga05034
Alcoholism
oga05132
Salmonella infection
oga05133
Pertussis
oga05135
Yersinia infection
oga05140
Leishmaniasis
oga05142
Chagas disease
oga05145
Toxoplasmosis
oga05152
Tuberculosis
oga05160
Hepatitis C
oga05161
Hepatitis B
oga05163
Human cytomegalovirus infection
oga05164
Influenza A
oga05165
Human papillomavirus infection
oga05166
Human T-cell leukemia virus 1 infection
oga05167
Kaposi sarcoma-associated herpesvirus infection
oga05170
Human immunodeficiency virus 1 infection
oga05171
Coronavirus disease - COVID-19
oga05200
Pathways in cancer
oga05203
Viral carcinogenesis
oga05205
Proteoglycans in cancer
oga05206
MicroRNAs in cancer
oga05207
Chemical carcinogenesis - receptor activation
oga05208
Chemical carcinogenesis - reactive oxygen species
oga05210
Colorectal cancer
oga05211
Renal cell carcinoma
oga05212
Pancreatic cancer
oga05213
Endometrial cancer
oga05214
Glioma
oga05215
Prostate cancer
oga05216
Thyroid cancer
oga05218
Melanoma
oga05219
Bladder cancer
oga05220
Chronic myeloid leukemia
oga05221
Acute myeloid leukemia
oga05223
Non-small cell lung cancer
oga05224
Breast cancer
oga05225
Hepatocellular carcinoma
oga05226
Gastric cancer
oga05230
Central carbon metabolism in cancer
oga05231
Choline metabolism in cancer
oga05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
oga05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
oga00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100957343 (MAPK3)
04012 ErbB signaling pathway
100957343 (MAPK3)
04014 Ras signaling pathway
100957343 (MAPK3)
04015 Rap1 signaling pathway
100957343 (MAPK3)
04350 TGF-beta signaling pathway
100957343 (MAPK3)
04370 VEGF signaling pathway
100957343 (MAPK3)
04371 Apelin signaling pathway
100957343 (MAPK3)
04668 TNF signaling pathway
100957343 (MAPK3)
04066 HIF-1 signaling pathway
100957343 (MAPK3)
04068 FoxO signaling pathway
100957343 (MAPK3)
04072 Phospholipase D signaling pathway
100957343 (MAPK3)
04071 Sphingolipid signaling pathway
100957343 (MAPK3)
04024 cAMP signaling pathway
100957343 (MAPK3)
04022 cGMP-PKG signaling pathway
100957343 (MAPK3)
04151 PI3K-Akt signaling pathway
100957343 (MAPK3)
04150 mTOR signaling pathway
100957343 (MAPK3)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
100957343 (MAPK3)
04148 Efferocytosis
100957343 (MAPK3)
09143 Cell growth and death
04114 Oocyte meiosis
100957343 (MAPK3)
04210 Apoptosis
100957343 (MAPK3)
04218 Cellular senescence
100957343 (MAPK3)
09144 Cellular community - eukaryotes
04510 Focal adhesion
100957343 (MAPK3)
04520 Adherens junction
100957343 (MAPK3)
04540 Gap junction
100957343 (MAPK3)
04550 Signaling pathways regulating pluripotency of stem cells
100957343 (MAPK3)
09142 Cell motility
04810 Regulation of actin cytoskeleton
100957343 (MAPK3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
100957343 (MAPK3)
04613 Neutrophil extracellular trap formation
100957343 (MAPK3)
04620 Toll-like receptor signaling pathway
100957343 (MAPK3)
04621 NOD-like receptor signaling pathway
100957343 (MAPK3)
04625 C-type lectin receptor signaling pathway
100957343 (MAPK3)
04650 Natural killer cell mediated cytotoxicity
100957343 (MAPK3)
04660 T cell receptor signaling pathway
100957343 (MAPK3)
04658 Th1 and Th2 cell differentiation
100957343 (MAPK3)
04659 Th17 cell differentiation
100957343 (MAPK3)
04657 IL-17 signaling pathway
100957343 (MAPK3)
04662 B cell receptor signaling pathway
100957343 (MAPK3)
04664 Fc epsilon RI signaling pathway
100957343 (MAPK3)
04666 Fc gamma R-mediated phagocytosis
100957343 (MAPK3)
04062 Chemokine signaling pathway
100957343 (MAPK3)
09152 Endocrine system
04910 Insulin signaling pathway
100957343 (MAPK3)
04929 GnRH secretion
100957343 (MAPK3)
04912 GnRH signaling pathway
100957343 (MAPK3)
04915 Estrogen signaling pathway
100957343 (MAPK3)
04914 Progesterone-mediated oocyte maturation
100957343 (MAPK3)
04917 Prolactin signaling pathway
100957343 (MAPK3)
04921 Oxytocin signaling pathway
100957343 (MAPK3)
04926 Relaxin signaling pathway
100957343 (MAPK3)
04935 Growth hormone synthesis, secretion and action
100957343 (MAPK3)
04919 Thyroid hormone signaling pathway
100957343 (MAPK3)
04928 Parathyroid hormone synthesis, secretion and action
100957343 (MAPK3)
04916 Melanogenesis
100957343 (MAPK3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
100957343 (MAPK3)
04270 Vascular smooth muscle contraction
100957343 (MAPK3)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
100957343 (MAPK3)
09156 Nervous system
04724 Glutamatergic synapse
100957343 (MAPK3)
04725 Cholinergic synapse
100957343 (MAPK3)
04726 Serotonergic synapse
100957343 (MAPK3)
04720 Long-term potentiation
100957343 (MAPK3)
04730 Long-term depression
100957343 (MAPK3)
04723 Retrograde endocannabinoid signaling
100957343 (MAPK3)
04722 Neurotrophin signaling pathway
100957343 (MAPK3)
09158 Development and regeneration
04360 Axon guidance
100957343 (MAPK3)
04380 Osteoclast differentiation
100957343 (MAPK3)
09159 Environmental adaptation
04713 Circadian entrainment
100957343 (MAPK3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100957343 (MAPK3)
05206 MicroRNAs in cancer
100957343 (MAPK3)
05205 Proteoglycans in cancer
100957343 (MAPK3)
05207 Chemical carcinogenesis - receptor activation
100957343 (MAPK3)
05208 Chemical carcinogenesis - reactive oxygen species
100957343 (MAPK3)
05203 Viral carcinogenesis
100957343 (MAPK3)
05230 Central carbon metabolism in cancer
100957343 (MAPK3)
05231 Choline metabolism in cancer
100957343 (MAPK3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100957343 (MAPK3)
09162 Cancer: specific types
05210 Colorectal cancer
100957343 (MAPK3)
05212 Pancreatic cancer
100957343 (MAPK3)
05225 Hepatocellular carcinoma
100957343 (MAPK3)
05226 Gastric cancer
100957343 (MAPK3)
05214 Glioma
100957343 (MAPK3)
05216 Thyroid cancer
100957343 (MAPK3)
05221 Acute myeloid leukemia
100957343 (MAPK3)
05220 Chronic myeloid leukemia
100957343 (MAPK3)
05218 Melanoma
100957343 (MAPK3)
05211 Renal cell carcinoma
100957343 (MAPK3)
05219 Bladder cancer
100957343 (MAPK3)
05215 Prostate cancer
100957343 (MAPK3)
05213 Endometrial cancer
100957343 (MAPK3)
05224 Breast cancer
100957343 (MAPK3)
05223 Non-small cell lung cancer
100957343 (MAPK3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100957343 (MAPK3)
05170 Human immunodeficiency virus 1 infection
100957343 (MAPK3)
05161 Hepatitis B
100957343 (MAPK3)
05160 Hepatitis C
100957343 (MAPK3)
05171 Coronavirus disease - COVID-19
100957343 (MAPK3)
05164 Influenza A
100957343 (MAPK3)
05163 Human cytomegalovirus infection
100957343 (MAPK3)
05167 Kaposi sarcoma-associated herpesvirus infection
100957343 (MAPK3)
05165 Human papillomavirus infection
100957343 (MAPK3)
09171 Infectious disease: bacterial
05132 Salmonella infection
100957343 (MAPK3)
05135 Yersinia infection
100957343 (MAPK3)
05133 Pertussis
100957343 (MAPK3)
05152 Tuberculosis
100957343 (MAPK3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
100957343 (MAPK3)
05140 Leishmaniasis
100957343 (MAPK3)
05142 Chagas disease
100957343 (MAPK3)
09164 Neurodegenerative disease
05010 Alzheimer disease
100957343 (MAPK3)
05020 Prion disease
100957343 (MAPK3)
05022 Pathways of neurodegeneration - multiple diseases
100957343 (MAPK3)
09165 Substance dependence
05034 Alcoholism
100957343 (MAPK3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100957343 (MAPK3)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
100957343 (MAPK3)
04933 AGE-RAGE signaling pathway in diabetic complications
100957343 (MAPK3)
04934 Cushing syndrome
100957343 (MAPK3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100957343 (MAPK3)
01524 Platinum drug resistance
100957343 (MAPK3)
01522 Endocrine resistance
100957343 (MAPK3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
oga01001
]
100957343 (MAPK3)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:
oga03036
]
100957343 (MAPK3)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:
oga04147
]
100957343 (MAPK3)
Enzymes [BR:
oga01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
100957343 (MAPK3)
Protein kinases [BR:
oga01001
]
Serine/threonine kinases: CMGC group
MAPK family [OT]
100957343 (MAPK3)
Chromosome and associated proteins [BR:
oga03036
]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
100957343 (MAPK3)
Exosome [BR:
oga04147
]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
100957343 (MAPK3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
ABC1
APH
Haspin_kinase
FTA2
Kdo
Motif
Other DBs
NCBI-GeneID:
100957343
NCBI-ProteinID:
XP_003795827
Ensembl:
ENSOGAG00000027841
LinkDB
All DBs
Position
Unknown
AA seq
379 aa
AA seq
DB search
MAAAAAQGGGGGEPRGADGVGLGVSGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAY
DHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRAPTLEAMRDVYI
VQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDL
KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS
NRPIFPGKHYLDQLNHILGILGSPSQEDLNCVINMKARNYLQSLPSKTKVAWAKLFPKSD
SKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFDMELDDLPKERL
KELIFQETARFQPGGLEAP
NT seq
1140 nt
NT seq
+upstream
nt +downstream
nt
atggcggcggcggcggctcaggggggcgggggcggggagccccggggagccgatggggtc
ggcctgggggtctcgggggaagtagagatggtgaaggggcagccgttcgacgtgggaccg
cgctacacgcagctgcaatacattggcgagggcgcctatggcatggtcagctcagcttat
gaccatgtgcgcaagactcgagtagccatcaagaagatcagccccttcgagcatcagacc
tactgccagcgcacgctacgggagatacagatcttacttcgattccgtcatgagaatgtc
attggcatcagagacattctgcgggcacccaccctggaagctatgagagatgtctacatt
gtgcaggacctgatggagacagacctatacaagttactcaaaagccagcagctgagcaac
gatcacatctgctacttcctctaccagatcctgcggggcctcaagtatatccactcagcc
aatgtgctccaccgagatctaaagccctctaacctgctcatcaacaccacctgtgacctt
aagatctgcgatttcggcctggcccggattgctgatcctgagcatgaccacactggcttt
ctgactgagtatgtggctacacgctggtaccgagccccagagatcatgctgaactccaag
ggctacaccaagtccatcgatatctggtctgtgggctgcattctggctgagatgctctct
aaccggcccatcttccctggcaagcactacctggatcagcttaaccacattctgggcatt
ctgggctccccatcccaagaggacctaaattgtgtcatcaacatgaaggcccgaaactac
ctacagtctctgccctccaagaccaaggtggcctgggccaaactttttcccaagtcagac
tccaaagcccttgacctgctggaccggatgttaactttcaaccccaacaaacggatcaca
gtggaggaagcactggctcacccctacctagagcagtactacgatccaacagatgagcca
gtggctgaggagcccttcacctttgatatggagctggatgatctacccaaggagcggctg
aaggagctcatcttccaggagacagcccgcttccagcctggggggctggaggccccataa
DBGET
integrated database retrieval system